BIO World Congress on Industrial Biotechnology workshops are designed for specific and focused discussions on business or technical information. Several Workshops are available for 2014. If you are interested in sponsorshing a workshop contact Sara Morgenstern at email@example.com.
Workshops are open to all attendees with a full conference registartion.
French Industrial Biotech Start-Ups
Moderator: Josko Bobanovic, Sofinnova Partners
Frédéric Caijo,Omega Cat System
Jean-Gabriel Levon, Ynsect
Pierre Calleja, Fermentalg
Four CEOs of French industrial biotech start-ups with breakthrough technologies, and looking for partnerships, will introduce their companies. The workshop will be moderated by Sofinnova, a leading European investment company in renewable chemicals. Presenting company profiles are shown below.
Omega Cat System develops catalysts for olefin metathesis. Their technology offers many advantages: high activity, better stability, less contamination and high cost efficiency. They are currently developing new applications.
Eviagenics has developed a highly efficient technology platform for rapid generation of cellular factories which allows assembly, homologous recombination and expression of divergent metabolic pathways in one step to produce flavor, fragrance, vitamins or amino acids.
Ynsect produces feed additives through the bioconversion of organic substrates by insects. Ynsect developed an insect hydrolysate having unique nutritional and functional properties.
Fermentalg has developed a unique technology using breeding microalgae in a predominantly heterotrophic/mixotrophic environment to produce molecules of interest for food, feed, green chemistry, healthcare, cosmetics and biofuels.
The New Age of Bio-based Polyamides - Current Trends and Uses
Moderator: Doug Weishaar, Evonik Corporation
Doug Weishaar, Evonik Corporation
Enrique Mejía, Proveedora Mexicana de Monofilamentos S.A. de C.V.
Brendan McSheehy, Universal Fibers, Inc.
Benjamin Brehmer, Evonik Industries AG
There is a recent trend towards an increasing utilization of bio-plastics. One reason is a rise in public awareness and willingness to utilize products produced from bio-plastics. Another decisive reason is the interest of companies to offer products from sustainable solutions with lower carbon footprints, reduced environment impact and freedom from dependence on fossil fuels.
Renewable raw materials help slow down climate change because they bind the greenhouse gas CO2 as they grow. They also help ensure security of supply—biomasses are continuously renewable and can be cultivated in many regions of the earth.
Unlike other bio-based polymers, biopolyamides are high-performance polymers. They are not disposable products, have no restrictions on their service life and do not give rise to technical weaknesses. On the contrary, biopolyamides are long-lived, durable and are used in demanding applications (e.g., mobility, sports, filaments/textiles, aerospace, construction and consumer products).
The panel will present and discuss current industry trends, developments, and commercial use of Bio-based polyamides.
Challenges and Opportunities for the Production of High Value Renewable Chemicals: New Technologies & Advancements
Moderator: JoAnne Carilli-Stevenson, Lonza
Jason Kelly, Ginkgo Bioworks
David Demirjian, zuChem
Joel Stone, Green Biologics
Lonza, a leading supplier to the life science industry, is pleased to present a panel of speakers who will present an overview of their journey towards the development of high value renewable chemicals. The panelists will discuss their company’s approach to commercialization of their targeted products.
Lonza will lead the panel with an introduction to biochemical innovation. Ginkgo Bioworks will describe their organism fabrication facility and the recent technology advances have enabled the economic production of high value natural ingredients via fermentation. zuChem will focus on the development and scale-up of glycochemicals and carbohydrates for use in the food, specialty and fine chemical markets. Green Biologics Ltd. (GBL) will discuss their interest in biobutanol and other C4 chemicals from various renewable feedstocks.
Building the Aviation Biofuels Supply Chain Network
Moderator: Jim Lane , Biofuels Digest
Steve Fabijanski, Agrisoma Biosciences Inc.
Brad Bly, Ag-West Bio Inc.
Ron Kehrig, Saskatchewan Ministry of the Economy
Rick Green, POS Bio-Sciences
"The Historic” Flight of the Century took place in Canada on October 29, 2012, where the world’s first 100% biofuel powered flight took place over Canada’s skies. This flight, and the scientific and engineering efforts leading up to the successful execution of the flight plan, demonstrates that Canada is leading the way in achieving a scalable aviation biofuel future. The partnerships and strategic partners involved in this accomplishment illustrate the strengths of Canada's world-class innovation system and its ability to leverage national and regional strengths to achieve world firsts.
We are looking beyond one of the greatest modern day scientific industry achievements to engage and advance the development of the supply chain for aviation biofuels. Applied Research Associates and Agrisoma Biosciences have partnered with the National Research Council of Canada (NRC) to develop a "sustainable source of renewable energy" for the commercial airline industry. Join us for an interactive workshop as we jointly explore the next steps towards a seed to sky strategy for aviation biofuels.
Financing the Commercialization of Global Biorefinery Projects
John May, Stern Brothers
John Kirkwood, Krieg Devault
Gabriel Lourenco Gomes, BNDES
Financing is the most important issue in the commercialization of biorefinery projects globally. This panel will explore the state of financing biofuel, biochemical, and biorefinery projects in North America and around the world - what has been financed and what hasn’t and why. They will provide an analysis of the debt markets, an analysis of the equity markets, and share their recommendations for specific financing strategies.
This panel will also examine the various issues surrounding accessing debt or equity financing for commercial scale biorefineries around the world. Those issues include project debt; project equity; federal, state, and local economic development incentives and subsidies.
They will also discuss the strategies of mitigating technology risk including: independent engineer reports, EPC wraps, contingent equity, federal and state loan guarantees, bilateral and multilateral loan guarantees, and technology risk insurance.
The panel will address other major project finance risks including feedstock, offtake, and construction risk.
They will also explore the development of due diligence in a data room and private placement memorandum for raising debt and raising equity. They will discuss the sources of project debt, including what works and what does not work, and the sources of project equity, including what works and what does not work. In addition, they will discuss considerations unique to projects outside the US and Canada including currency risk, political risk, and various legal risks.
Biobased Products Advocacy Consortium (B2PAC) Presents - - Commercializing Renewable Chemicals and TSCA: Getting To Yes
Lynn L. Bergeson, Bergeson & Campbell, P.C.
Kathleen M. Roberts, B&C Consortia Management
Renewable chemicals are emerging at a fast pace, paving the way for new, innovative, and sustainable biobased products. A variety of technologies are enhancing the commercial potential of enzymes, new microbes, biomass, and other bio-engineered material, further enabling the commercialization of high-quality, efficacious, and diverse biobased products.
The U.S. Environmental Protection Agency (EPA) regulates all industrial commercial chemical substances under the Toxic Substances Control Act (TSCA). TSCA's provisions apply to all chemical substances (unless otherwise exempted), whether the product of conventional manufacturing technologies derivative of petroleum or new technologies utilizing renewable feedstocks TSCA is an old law that is being stretched to apply to emerging technologies. Often the fit is awkward and results in commercial and regulatory anomalies that can significantly diminish the commercial promise of a new technology. Understanding how, when, and to which entity in the value chain TSCA applies, and what a renewable chemical developer must do to comply with TSCA's requirements are critically important components of any company's commercialization game-plan and ultimate market success.
• Highlight some of EPA's program initiatives promoting the development of renewable chemicals;
• Provide an overview of renewable chemical products, TSCA, and new chemicals;
• Explain TSCA's naming conventions and the TSCA Inventory;
• Review what EPA looks for in reviewing chemical premanufacture notifications; and
• Highlight regulatory opportunities and challenges renewable chemicals present to EPA and entities subject to TSCA.